Enterprise Financial Services Corp Novo Cure LTD Transaction History

Enterprise Financial Services Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $2,671 - $4,474	-23 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $521 - $902	4 Added 21.05%	23 $5,000
Q1 2021 May 13, 2021	BUY	$124.11 - $190.17 $1,861 - $2,852	15 Added 375.0%	19 $3,000
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $448 - $696	4 New	4 $1,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.